Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2024)
Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology

Overview Zen Score Price Valuation Financials

Forecast Earnings & Revenue Dividends Ownership Technicals

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
INCY	INCYTE CORP	$11.60B	12.40%	9.50%	15.10%	46.10%	0.31	3.75	93.10%	16.20%	22.64%
HRMY	HARMONY BIOSCIENCES HOLDINGS INC	$1.66B	27.50%	16.80%	30.44%	50.60%	0.74	2.75	79.20%	22.10%	33.87%
VYGR	VOYAGER THERAPEUTICS INC	$413.77M	63.90%	40.80%	42.55%	106.20%	0.49	4.96	100.00%	52.90%	48.81%
AMLX	AMYLYX PHARMACEUTICALS INC	$119.30M	12.40%	10.70%	12.47%	22.80%	0.19	5.66	93.30%	12.90%	14.26%
UTHR	UNITED THERAPEUTICS CORP	$11.00B	17.70%	14.50%	20.96%	22.90%	0.20	4.41	88.90%	42.30%	57.30%
EXEL	EXELIXIS INC	$7.19B	8.60%	6.80%	10.11%	10.70%	0.30	3.34	96.00%	11.40%	14.07%
CORT	CORCEPT THERAPEUTICS INC	$2.36B	22.00%	17.90%	20.63%	34.40%	0.23	4.39	98.70%	21.90%	22.11%
BMRN	BIOMARIN PHARMACEUTICAL INC	$15.36B	4.20%	3.00%	4.40%	4.50%	0.36	2.74	79.20%	8.30%	10.30%
PBYI	PUMA BIOTECHNOLOGY INC	$242.00M	58.20%	10.40%	27.45%	31.30%	3.31	1.57	73.40%	9.20%	15.28%
HALO	HALOZYME THERAPEUTICS INC	$4.89B	204.80%	15.80%	22.65%	17.70%	19.68	6.64	76.80%	34.00%	44.27%
RPRX	ROYALTY PHARMA PLC	$16.73B	11.50%	6.80%	8.15%	6.20%	0.62	7.90	100.00%	48.20%	56.15%
TGTX	TG THERAPEUTICS INC	$2.08B	12.90%	4.70%	9.31%	12.00%	1.05	5.92	94.00%	5.40%	10.99%
ROIV	ROIVANT SCIENCES LTD	$8.89B	196.20%	128.50%	64.37%	590.00%	0.12	27.79	87.60%	3,624.10%	3,691.45%
GMAB	GENMAB A	$18.60B	14.70%	13.10%	21.49%	38.10%	0.12	13.34	98.60%	26.40%	42.80%
MEIP	MEI PHARMA INC	$20.32M	39.70%	18.30%	28.15%	27.70%	0.32	8.23	100.00%	27.30%	27.32%
MDXG	MIMEDX GROUP INC	$921.43M	205.30%	30.10%	14.44%	27.90%	0.68	3.57	83.00%	18.10%	8.67%
BNTX	BIONTECH SE	$20.73B	4.60%	4.20%	5.78%	16.10%	0.14	9.43	84.30%	24.40%	31.68%
VNDA	VANDA PHARMACEUTICALS INC	$265.82M	0.50%	0.40%	1.13%	2.00%	0.19	4.94	92.30%	1.30%	3.29%
REGN	REGENERON PHARMACEUTICALS INC	$96.94B	16.10%	12.60%	14.41%	15.70%	0.27	5.69	86.20%	30.10%	32.57%
DBVT	DBV TECHNOLOGIES SA	$131.53M	-46.40%	-35.30%	-49.93%	-670.90%	0.31	4.26	100.00%	-462.40%	-462.35%
PLX	PROTALIX BIOTHERAPEUTICS INC	$84.01M	29.70%	10.20%	26.89%	24.60%	1.52	1.54	64.90%	12.70%	15.97%
AVRO	AVROBIO INC	$54.28M	13.00%	11.30%	10.68%	396.50%	0.07	15.78	N/A	N/A	N/A
SPRO	SPERO THERAPEUTICS INC	$78.65M	32.60%	18.20%	17.49%	130.70%	0.71	3.53	100.00%	22.00%	24.48%
BNOX	BIONOMICS LIMITED	$11.55M	-80.80%	-65.20%	-89.96%	28,812.60%	0.34	3.81	100.00%	-140,642.50%	-140,487.81%
VRTX	VERTEX PHARMACEUTICALS INC	$102.67B	22.60%	17.30%	23.06%	69.80%	0.29	3.99	87.20%	36.70%	44.83%
KRYS	KRYSTAL BIOTECH INC	$4.44B	1.60%	1.50%	1.64%	3.20%	0.05	17.77	93.90%	21.60%	25.44%
CRSP	CRISPR THERAPEUTICS AG	$4.33B	-8.40%	-7.00%	-7.11%	-8.10%	0.18	17.54	100.00%	-41.40%	-40.60%
CPRX	CATALYST PHARMACEUTICALS INC	$1.75B	19.80%	16.50%	23.98%	190.70%	0.21	2.88	86.90%	17.90%	23.73%
SEER	SEER INC	$123.72M	-20.90%	-19.00%	-20.39%	-20.30%	0.10	25.00	51.10%	-517.80%	-517.84%
KNSA	KINIKSA PHARMACEUTICALS LTD	$1.27B	2.10%	1.70%	-4.73%	-6.70%	0.20	4.21	87.80%	2.90%	-7.15%
TFFP	TFF PHARMACEUTICALS INC	$7.36M	-163.10%	-144.80%	-221.31%	-476.70%	0.26	3.13	100.00%	-2,894.70%	-2,894.68%
OCUP	OCUPHIRE PHARMA INC	$39.95M	-22.30%	-20.30%	-19.99%	-544.60%	0.08	13.35	100.00%	-52.40%	-52.36%
ADAG	ADAGENE INC	$105.44M	-24.70%	-14.10%	-19.16%	148.00%	0.64	3.61	100.00%	-104.60%	-89.15%
MIRM	MIRUM PHARMACEUTICALS INC	$1.15B	-88.60%	-31.50%	-26.33%	-48.60%	1.60	4.45	74.80%	-87.70%	-79.04%
NVO	NOVO NORDISK A S	$572.09B	90.50%	29.20%	72.53%	130.90%	1.95	0.82	84.60%	36.00%	45.23%
PRTA	PROTHENA CORP PUBLIC LTD CO	$1.12B	-24.80%	-20.20%	-25.09%	-963.10%	0.24	11.24	100.00%	-160.90%	-175.64%
IDYA	IDEAYA BIOSCIENCES INC	$2.98B	-23.00%	-21.80%	-18.15%	-30.20%	0.05	19.65	100.00%	-483.00%	-483.05%
VYNE	VYNE THERAPEUTICS INC	$35.25M	-79.10%	-64.20%	-31.56%	-217.40%	0.10	12.73	100.00%	-6,710.40%	-6,710.38%
IMMP	IMMUTEP LTD	$315.04M	-42.10%	-38.60%	-34.53%	-1,232.30%	0.07	17.24	100.00%	-602.00%	-601.76%
AGIO	AGIOS PHARMACEUTICALS INC	$1.77B	-38.10%	-33.70%	-40.51%	-35.90%	0.16	12.27	89.30%	-1,312.60%	-1,312.63%
CLGN	COLLPLANT BIOTECHNOLOGIES LTD	$67.46M	-22.20%	-18.80%	-24.33%	-66.60%	0.20	8.62	81.80%	-64.00%	-68.55%
VTGN	VISTAGEN THERAPEUTICS INC	$128.37M	-72.10%	-61.30%	-25.27%	-922.40%	0.06	30.76	100.00%	-3,076.60%	-3,076.34%
RNA	AVIDITY BIOSCIENCES INC	$1.94B	-39.70%	-35.00%	-38.74%	-50.00%	0.26	7.58	100.00%	-2,219.90%	-2,219.87%
JAZZ	JAZZ PHARMACEUTICALS PLC	$6.82B	11.80%	3.70%	5.93%	8.20%	2.05	2.24	88.60%	10.80%	15.24%
ARCT	ARCTURUS THERAPEUTICS HOLDINGS INC	$714.60M	-10.10%	-6.60%	-12.80%	-105.70%	0.54	4.72	100.00%	-17.80%	-26.67%
LPCN	LIPOCINE INC	$25.51M	-63.30%	-58.30%	-80.27%	-76.90%	0.13	8.69	100.00%	573.60%	573.57%
INM	INMED PHARMACEUTICALS INC	$1.39M	-54.30%	-46.20%	-46.76%	-379.90%	0.19	7.03	38.40%	-115.80%	-115.69%
ALGS	ALIGOS THERAPEUTICS INC	$59.17M	-116.40%	-75.40%	-69.05%	-1,017.50%	0.65	5.90	100.00%	-564.60%	-567.50%
MDWD	MEDIWOUND LTD	$168.20M	-20.20%	-10.10%	-8.34%	-11.80%	1.10	4.59	19.10%	-35.90%	-24.83%
KZR	KEZAR LIFE SCIENCES INC	$58.61M	-45.90%	-40.00%	-49.30%	-44.10%	0.18	11.66	100.00%	-1,455.30%	-1,433.14%
ORMP	ORAMED PHARMACEUTICALS INC	$99.68M	3.60%	2.90%	4.52%	4.20%	0.35	3.06	100.00%	412.30%	564.33%
GNFT	GENFIT SA	$173.92M	-35.60%	-14.80%	-16.91%	-30.40%	1.56	2.94	100.00%	-75.70%	-59.99%
ZLAB	ZAI LAB LTD	$1.58B	-37.10%	-30.70%	-40.16%	-273.40%	0.30	4.63	64.10%	-125.50%	-125.46%
TECH	BIO-TECHNE CORP	$10.07B	11.50%	8.40%	10.12%	18.30%	0.39	4.37	67.10%	19.60%	22.94%
EDIT	EDITAS MEDICINE INC	$435.25M	-43.00%	-30.50%	-39.18%	-50.00%	0.43	5.39	100.00%	-196.10%	-218.61%
PTGX	PROTAGONIST THERAPEUTICS INC	$1.47B	-27.50%	-25.30%	-23.45%	-83.60%	0.06	16.71	100.00%	-131.60%	-131.59%
LEGN	LEGEND BIOTECH CORP	$8.24B	-44.60%	-30.40%	-30.53%	-73.10%	0.48	6.92	49.40%	-181.80%	-174.76%
XCUR	EXICURE INC	$4.32M	34.50%	13.10%	20.31%	25.00%	0.81	2.56	100.00%	12.90%	13.76%
ANIX	ANIXA BIOSCIENCES INC	$103.04M	-42.40%	-40.90%	-45.31%	-48.80%	0.07	15.19	23.30%	-5,116.20%	-5,116.19%
FULC	FULCRUM THERAPEUTICS INC	$442.22M	-36.60%	-33.60%	-39.89%	-38.20%	0.10	17.71	100.00%	-3,470.10%	-3,470.05%
GLPG	GALAPAGOS NV	$1.90B	8.00%	4.70%	5.63%	6.20%	0.56	9.02	100.00%	88.30%	92.32%
LIFE	ATYR PHARMA INC	$106.37M	-49.70%	-39.10%	-48.34%	-45.70%	0.33	6.27	100.00%	-14,274.50%	-14,274.50%
AXSM	AXSOME THERAPEUTICS INC	$3.40B	-112.40%	-43.70%	-51.59%	-138.50%	2.08	3.63	90.40%	-88.40%	-85.67%
SLGL	SOL-GEL TECHNOLOGIES LTD	$24.79M	-62.60%	-54.70%	-66.82%	-112.20%	0.17	9.10	100.00%	-1,752.80%	-1,752.77%
FUSN	FUSION PHARMACEUTICALS INC	$1.81B	-46.60%	-35.30%	-32.99%	-34.50%	0.29	15.01	100.00%	-4,588.80%	-4,300.97%
ACIU	AC IMMUNE SA	$233.11M	-37.50%	-33.30%	-31.94%	-105.20%	0.14	9.22	100.00%	-366.40%	-365.16%
MRUS	MERUS NV	$2.61B	-50.60%	-37.60%	-43.03%	-86.50%	0.28	5.34	100.00%	-352.60%	-378.31%
XBIO	XENETIC BIOSCIENCES INC	$6.30M	-36.40%	-33.70%	-42.21%	-419.10%	0.08	11.84	100.00%	-162.80%	-162.78%
FATE	FATE THERAPEUTICS INC	$377.10M	-38.20%	-28.40%	-34.45%	-28.10%	0.37	8.48	100.00%	-253.30%	-253.30%
ARGX	ARGENX SE	$22.07B	-8.50%	-7.70%	-7.37%	-15.80%	0.11	9.75	-231.60%	-830.40%	-854.39%
NRBO	NEUROBO PHARMACEUTICALS INC	$15.40M	-59.40%	-45.40%	-74.13%	215.70%	0.37	3.78	N/A	N/A	N/A
BOLT	BOLT BIOTHERAPEUTICS INC	$42.32M	-51.20%	-37.80%	-49.66%	-40.20%	0.42	5.17	100.00%	-878.60%	-878.58%
VERV	VERVE THERAPEUTICS INC	$515.09M	-39.30%	-30.90%	-27.92%	-35.30%	0.26	17.24	100.00%	-1,701.50%	-1,699.21%
IGMS	IGM BIOSCIENCES INC	$552.59M	-103.20%	-53.50%	-64.51%	-78.50%	1.08	8.18	100.00%	-11,568.80%	-11,537.00%
ZVRA	ZEVRA THERAPEUTICS INC	$196.29M	-68.40%	-35.20%	-45.18%	-73.00%	1.79	1.18	89.30%	-167.70%	-162.22%
MRKR	MARKER THERAPEUTICS INC	$38.19M	-50.10%	-38.10%	-58.59%	-143.70%	0.22	5.57	100.00%	-248.80%	-248.65%
CLNN	CLENE INC	$43.67M	-362.00%	-89.80%	-166.40%	-122.70%	2.91	1.53	81.50%	-7,569.40%	-6,872.48%
TRAW	TRAWS PHARMA INC	$13.07M	-113.20%	-65.80%	-140.74%	240.20%	1.13	2.46	100.00%	-8,384.10%	-8,384.07%
BCYC	BICYCLE THERAPEUTICS PLC	$967.98M	-57.80%	-34.10%	-33.46%	-244.40%	0.61	8.08	100.00%	-669.70%	-652.22%
JANX	JANUX THERAPEUTICS INC	$2.45B	-17.90%	-16.00%	-15.87%	-16.70%	0.11	26.80	100.00%	-721.20%	-721.18%
ALT	ALTIMMUNE INC	$514.70M	-52.00%	-47.30%	-44.54%	-153.20%	0.09	17.26	100.00%	-20,762.20%	-20,753.99%
SPRB	SPRUCE BIOSCIENCES INC	$28.80M	-52.30%	-39.80%	-59.68%	-459.90%	0.36	4.18	100.00%	-475.00%	-470.18%
ARDX	ARDELYX INC	$1.49B	-43.60%	-26.00%	-24.50%	-31.10%	0.78	4.88	85.70%	-53.10%	-48.67%
BGNE	BEIGENE LTD	$16.08B	-23.10%	-15.30%	-22.52%	-54.70%	0.64	2.32	84.50%	-35.90%	-36.60%
RVMD	REVOLUTION MEDICINES INC	$5.92B	-38.40%	-33.60%	-22.92%	-59.70%	0.13	13.06	100.00%	-3,768.30%	-3,796.10%
CDIO	CARDIO DIAGNOSTICS HOLDINGS INC	$14.90M	-289.40%	-130.20%	-45.34%	1,418.50%	0.51	3.29	100.00%	-49,087.80%	-9,620.98%
SPRY	ARS PHARMACEUTICALS INC	$805.79M	-22.20%	-21.50%	-23.56%	-33.90%	0.01	96.92	100.00%	-181,216.70%	-181,216.67%
CALT	CALLIDITAS THERAPEUTICS AB	$580.94M	-84.70%	-24.50%	-23.60%	-43.10%	4.55	3.13	95.00%	-38.60%	-28.39%
ZYME	ZYMEWORKS INC	$582.89M	-26.20%	-20.30%	-22.71%	-31.70%	0.25	7.41	100.00%	-156.10%	-156.87%
ITOS	ITEOS THERAPEUTICS INC	$387.11M	-18.40%	-16.20%	-17.37%	-24.50%	0.16	13.76	100.00%	-894.30%	-865.66%
EYPT	EYEPOINT PHARMACEUTICALS INC	$834.67M	-61.50%	-33.50%	-23.80%	-1,558.50%	0.33	5.45	89.90%	-153.80%	-150.95%
BRNS	BARINTHUS BIOTHERAPEUTICS PLC	$97.30M	-35.20%	-30.80%	-37.84%	-244.70%	0.15	12.46	100.00%	-9,145.50%	-9,525.44%
RYTM	RHYTHM PHARMACEUTICALS INC	$2.30B	-96.00%	-55.00%	-61.33%	-88.40%	0.96	5.58	88.00%	-238.50%	-219.85%
PLRX	PLIANT THERAPEUTICS INC	$711.42M	-31.20%	-29.00%	-33.10%	-33.90%	0.08	17.72	100.00%	-10,211.10%	-10,130.95%
CMRX	CHIMERIX INC	$80.29M	-37.90%	-35.00%	-42.24%	-41.00%	0.10	10.25	100.00%	-25,338.00%	-25,337.96%
VCYT	VERACYTE INC	$1.45B	-7.00%	-6.50%	-7.27%	-124.00%	0.07	4.66	68.70%	-20.60%	-21.22%
IMTX	IMMATICS NV	$847.42M	-43.50%	-22.30%	-27.44%	-52.40%	1.27	2.87	100.00%	-179.60%	-179.63%
QSI	QUANTUM-SI INC	$233.92M	-31.50%	-29.00%	-33.48%	-40.70%	0.10	22.94	45.10%	-8,868.80%	-8,868.76%
CRNX	CRINETICS PHARMACEUTICALS INC	$2.93B	-52.90%	-45.50%	-36.27%	-54.80%	0.18	13.07	100.00%	-5,345.90%	-5,345.85%
OCS	OCULIS HOLDING AG	$440.53M	N/A	-117.30%	-91.72%	-108.20%	0.22	5.29	100.00%	-10,056.90%	-9,895.81%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Apr 2024?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the top biotech stock with a Zen Score of 75, which is 52 points higher than the biotech industry average of 23. It passed 24 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -29.72% over the past year, underperforming other biotech stocks by -8 percentage points.

Incyte has an average 1 year price target of $74.69, an upside of 44.53% from Incyte's current stock price of $51.68.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 23.08% have issued a Strong Buy rating, 23.08% have issued a Buy, 53.85% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second best biotech stock with a Zen Score of 70, which is 47 points higher than the biotech industry average of 23. It passed 23 out of 33 due diligence checks and has strong fundamentals. Harmony Biosciences Holdings has seen its stock lose -7.45% over the past year, overperforming other biotech stocks by 15 percentage points.

Harmony Biosciences Holdings has an average 1 year price target of $37.33, an upside of 27.33% from Harmony Biosciences Holdings's current stock price of $29.32.

Harmony Biosciences Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Harmony Biosciences Holdings, 33.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 16.67% have issued a Sell rating, and 16.67% have issued a Strong Sell.

3. Voyager Therapeutics (NASDAQ:VYGR)

Voyager Therapeutics (NASDAQ:VYGR) is the third best biotech stock with a Zen Score of 66, which is 43 points higher than the biotech industry average of 23. It passed 21 out of 33 due diligence checks and has strong fundamentals. Voyager Therapeutics has seen its stock return 2.42% over the past year, overperforming other biotech stocks by 25 percentage points.

Voyager Therapeutics has an average 1 year price target of $20.50, an upside of 169.03% from Voyager Therapeutics's current stock price of $7.62.

Voyager Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Voyager Therapeutics, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 4 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Carisma Therapeutics (NASDAQ:CARM)

Carisma Therapeutics (NASDAQ:CARM) has an annual dividend yield of N/A, which is N/A percentage points lower than the biotech industry average of 15.1%.

Carisma Therapeutics's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

2. Mei Pharma (NASDAQ:MEIP)

Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 57.38%, which is 42 percentage points higher than the biotech industry average of 15.1%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

3. Novo Nordisk A S (NYSE:NVO)

Novo Nordisk A S (NYSE:NVO) has an annual dividend yield of 1.08%, which is -14 percentage points lower than the biotech industry average of 15.1%. Novo Nordisk A S's dividend payout is not stable, having dropped more than 10% eight times in the last 10 years. Novo Nordisk A S's dividend has shown consistent growth over the last 10 years.

Novo Nordisk A S's dividend payout ratio of 38.1% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 1.2% in the last day, and up 1.13% over the last week. Biodexa Pharmaceuticals was the among the top gainers in the biotechnology industry, gaining 79.31% yesterday.

Biodexa shares are trading higher after the company entered an exclusive license agreement with Rapamycin Holdings for the rights to eRapa.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Voyager Therapeutics (NASDAQ:VYGR)

Voyager Therapeutics (NASDAQ:VYGR) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Voyager Therapeutics has a valuation score of 100, which is 86 points higher than the biotech industry average of 14. It passed 7 out of 7 valuation due diligence checks.

Voyager Therapeutics's stock has gained 2.42% in the past year. It has overperformed other stocks in the biotech industry by 25 percentage points.

2. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Royalty Pharma has a valuation score of 100, which is 86 points higher than the biotech industry average of 14. It passed 7 out of 7 valuation due diligence checks.

Royalty Pharma's stock has dropped -20.21% in the past year. It has overperformed other stocks in the biotech industry by 2 percentage points.

3. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Incyte has a valuation score of 86, which is 72 points higher than the biotech industry average of 14. It passed 6 out of 7 valuation due diligence checks.

Incyte's stock has dropped -29.72% in the past year. It has underperformed other stocks in the biotech industry by -8 percentage points.

Are biotech stocks a good buy now?

49.23% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 91.76% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 14.88x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.